Imipramine Created 2026-10-25 Updated 2026-11-05
Imipramine is a tricyclic antidepressant affecting monoamine uptake and several receptor systems. Its regulatory description distinguishes observed pharmacological actions from a fully established explanation of clinical benefit.[ref]